Kaspera, Rüdiger <br/><br/>
Drug metabolism by CYP2C8.3 is determined by substrate dependent interactions with cytochrome P450 reductase and cytochrome b5.  [electronic resource] 

 -  Biochemical pharmacology  Sep 2011 
 - 681-91 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1873-2968 
<br/><br/><label>Standard No.: </label>10.1016/j.bcp.2011.06.027  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amino Acid Sequence<br/>Animals<br/>Aryl Hydrocarbon Hydroxylases--genetics<br/>Catalysis<br/>Cytochrome P-450 CYP2C8<br/>Cytochromes b5--genetics<br/>Escherichia coli--enzymology<br/>Humans<br/>In Vitro Techniques<br/>Inactivation, Metabolic<br/>Kinetics<br/>Microsomes, Liver--drug effects<br/>Models, Molecular<br/>Molecular Sequence Data<br/>NADPH-Ferrihemoprotein Reductase--genetics<br/>Oxidation-Reduction<br/>Pharmaceutical Preparations--metabolism<br/>Polymorphism, Genetic<br/>Protein Binding<br/>Rats<br/>Recombinant Proteins--genetics<br/>Sequence Alignment<br/>Substrate Specificity